Literature DB >> 15767077

Clinical examination accurately locates capillary nonperfusion in diabetic retinopathy.

James A Kimble1, Bari M Brandt, Gerald McGwin.   

Abstract

PURPOSE: To help the ophthalmologist who wishes to know the perfusion status of the retina outside the macula, we determined whether clinical examination can predict capillary nonperfusion in diabetic retinopathy (DR) as accurately as fluorescein angiography (FA).
DESIGN: Prospective observational case series.
SETTING: Clinical practice. STUDY POPULATION: Both eyes of 20 patients with clinically significant diabetic macular edema (CSME). OBSERVATION PROCEDURE: The location of capillary nonperfusion was recorded following 90-diopter lens slit-lamp biomicroscopy, and the same measurements made on FA. MAIN OUTCOME MEASURE: In the nasal and temporal quadrants of each eye, the clinical results were compared with the "gold standard" FA.
RESULTS: Most patients (84%) had definite peripheral capillary nonperfusion. Biomicroscopy results were highly correlated with angiography, with only a few differences of clinical importance.
CONCLUSIONS: Clinical examination can determine the location of capillary nonperfusion in DR with a high degree of accuracy.

Entities:  

Mesh:

Year:  2005        PMID: 15767077     DOI: 10.1016/j.ajo.2004.08.073

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

Review 1.  Ultra widefield fundus imaging for diabetic retinopathy.

Authors:  Szilárd Kiss; Thomas L Berenberg
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

2.  Angiogenic Factors and Cytokines in Diabetic Retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Clin Cell Immunol       Date:  2013

Review 3.  Diabetic macular edema: New promising therapies.

Authors:  Hanan N Al Shamsi; Jluwi S Masaud; Nicola G Ghazi
Journal:  World J Diabetes       Date:  2013-12-15

Review 4.  Diabetic Macular Edema: From Old Concepts to New Therapeutic Avenues.

Authors:  Ahmad M Mansour; Jose S Pulido; J Fernando Arevalo
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2015

5.  ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSION.

Authors:  Sophie Bonnin; Bénédicte Dupas; Carlo Lavia; Ali Erginay; Myriam Dhundass; Aude Couturier; Alain Gaudric; Ramin Tadayoni
Journal:  Retina       Date:  2019-03       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.